Benzinga | May 27, 2021 08:33AM EDT

DarioHealth Highlights Publication Of Study In Journal of Diabetes Science and Technology

DarioHealth Corp. (NASDAQ:DRIO), a pioneer in the global digital therapeutics market, today announced the publication of a new study through a Letter to the Editor in the Journal of Diabetes Science and Technology. The study is titled "Digital Therapeutics for Type 2 Diabetes: Incorporating Coaching Support and Validating Digital Monitoring.